Zhijie Chen
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Targeting DDX3X suppresses progression of KRAS-driven lung cancer by disrupting antioxidative homeostasis and inducing ferroptosis.
Journal: Cell death & disease
Published: March 03, 2025
Jaceosidin overcomes osimertinib resistance in lung cancer by inducing G2/M cycle arrest through targeting DDB1.
Journal: Toxicology and applied pharmacology
Published: December 30, 2024
Dihydroartemisinin Sensitizes Lung Cancer Cells to Cisplatin Treatment by Upregulating ZIP14 Expression and Inducing Ferroptosis.
Journal: Cancer medicine
Published: July 11, 2024
Impact of Altered Gut Microbiota on Ketamine-Induced Conditioned Place Preference in Mice.
Journal: Neuropsychiatric disease and treatment
Published: July 09, 2024
Host miR-129-5p reverses effects of ginsenoside Rg1 on morphine reward possibly mediated by changes in B. vulgatus and serotonin metabolism in hippocampus.
Journal: Gut microbes
Published: September 12, 2023
TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases.
Journal: Heliyon
Published: March 19, 2023
Ginsenoside Rg1 mitigates morphine dependence via regulation of gut microbiota, tryptophan metabolism, and serotonergic system function.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 11, 2022
Decrease of morphine-CPP by sinomenine via mediation of tyrosine hydroxylase, NMDA receptor subunit 2B and opioid receptor in the zebrafish brain.
Journal: Pakistan journal of pharmaceutical sciences
Published: November 22, 2021
Last Updated: 09/26/2026